98 evolution "https:" "https:" "https:" "https:" "https:" "Humboldt Universität zu Berlin" PhD positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
is accessible online: https://www.tec21.fr/phd-tec21 What we offer : 7 fully funded PhD positions with employment contract, competitive salary (monthly estimate net salary between 2 050 and 2 150 EUR
-
ATMPs via the European Medicines Agency: https://www.ema.europa.eu/en/human-regulatory-overview/advanced-therapy-medicinal-products-overview If you are curious, internationally minded, and driven by a
-
(cover letter) Vision for teaching and research CV including employment history, list of publications indicating scientific highlights, H-index and ORCID (see http://orcid.org/ ) Teaching portfolio
-
development support. Qualifications Specific Requirements MSc in Pharmacy; Experience with amino acid transporters; Experience with pharmaceutical application of drug transporters; Strong motivation and
-
the ongoing research lines at IRBLleida. 1.2. Summary Researchers wishing to apply to a forthcoming ICREA 2026 Senior Researcher position (https://www.icrea.cat/en/calls ) or already holding an ICREA
-
Smet ( https://desmetlab.sites.vib.be ) and F. Van Breusegem ( https://vanbreusegemlab.sites.vib.be ) have expertise in abiotic stress signaling and in advanced molecular profiling, including mass
-
. The position is embedded in a broader research agenda on trustworthy, data-driven software engineering and AI-assisted development. The successful candidate will work on Bug Report Intelligence
-
. Benefits and salary The successful candidates will receive an attractive salary in accordance with the MSCA regulations for Early-Stage Researchers (http://ec.europa.eu/research/mariecurieactions
-
well as multifold training and support for PhD students in framework of ISAS and the Leibniz association Training and scientific development opportunities in an international environment and an excellent working
-
the development of scalable software tools and pipelines, potentially leveraging GPU/FPGA accelerators. Our aim is to build next-generation molecular atlases for chronic diseases and to improve patient